tiprankstipranks
Trending News
More News >
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market

Tenaya Therapeutics (TNYA) Income Statement

Compare
2,950 Followers

Tenaya Therapeutics Income Statement

Last quarter (Q3 2025), Tenaya Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Tenaya Therapeutics's net income was $-20.27M. See Tenaya Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -8.47M$ -8.69M$ -8.71M$ -4.03M$ -2.48M
Operating Expenses
$ 107.48M$ 122.51M$ 116.91M$ 68.78M$ 36.43M
Depreciation and Amortization
$ 8.47M$ 8.69M$ 8.71M$ 4.03M$ 2.48M
EBITDA
$ -102.66M$ -115.40M$ -114.95M$ -68.70M$ -35.91M
Operating Income
$ -115.95M$ -131.19M$ -125.62M$ -72.81M$ -38.91M
Other Income/Expenses
$ 4.82M$ 7.11M$ 1.96M$ 85.00K$ 517.00K
Pretax Income
$ -111.13M$ -124.08M$ -123.67M$ -72.72M$ -38.40M
Net Income
$ -111.13M$ -124.08M$ -123.67M$ -72.72M$ -38.40M
Per Share Metrics
Basic EPS
$ -1.31$ -1.68$ -2.76$ -1.69$ -0.93
Diluted EPS
$ -1.31$ -1.68$ -2.76$ -1.69$ -0.93
Weighted Average Shares Outstanding
84.82M 73.79M 44.82M 41.29M 41.12M
Weighted Average Shares Outstanding (Diluted)
84.82M 73.79M 44.82M 41.29M 41.12M
Currency in USD

Tenaya Therapeutics Earnings and Revenue History